BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33928707)

  • 21. The NKG2D axis: an emerging target in cancer immunotherapy.
    Lazarova M; Steinle A
    Expert Opin Ther Targets; 2019 Apr; 23(4):281-294. PubMed ID: 30732494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Let-7b is involved in the inflammation and immune responses associated with Helicobacter pylori infection by targeting Toll-like receptor 4.
    Teng GG; Wang WH; Dai Y; Wang SJ; Chu YX; Li J
    PLoS One; 2013; 8(2):e56709. PubMed ID: 23437218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased invariant natural killer T-cell-mediated antitumor immune response in patients with gastric cancer.
    Ascui G; Gálvez-Jirón F; Kramm K; Schäfer C; Siña J; Pola V; Cristi F; Hernández C; Garrido-Tapia M; Pesce B; Bustamante M; Fluxá P; Molina MC; Ribeiro CH
    Immunol Cell Biol; 2020 Jul; 98(6):500-513. PubMed ID: 32189398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The killing effect of Tanshinol on breast cancer cells: insight into the reversion of TGF-β1-mediated suppression of NK cell functions.
    Yang C; Qian C; Zhang T; Zheng W; Zhang S; Wang S; Wang A; Zhao Y; Lu Y
    Front Biosci (Landmark Ed); 2021 Nov; 26(11):1106-1118. PubMed ID: 34856757
    [No Abstract]   [Full Text] [Related]  

  • 25. Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia.
    Landerer H; Arnone M; Wieboldt R; Goersch E; Stanger AMP; Konantz M; Lengerke C
    J Vis Exp; 2021 Feb; (168):. PubMed ID: 33682851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arming cytotoxic lymphocytes for cancer immunotherapy by means of the NKG2D/NKG2D-ligand system.
    Lazarova M; Wels WS; Steinle A
    Expert Opin Biol Ther; 2020 Dec; 20(12):1491-1501. PubMed ID: 32726145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis.
    Ishihara S; Rumi MA; Kadowaki Y; Ortega-Cava CF; Yuki T; Yoshino N; Miyaoka Y; Kazumori H; Ishimura N; Amano Y; Kinoshita Y
    J Immunol; 2004 Jul; 173(2):1406-16. PubMed ID: 15240737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MICAgen Mice Recapitulate the Highly Restricted but Activation-Inducible Expression of the Paradigmatic Human NKG2D Ligand MICA.
    Kim Y; Born C; Bléry M; Steinle A
    Front Immunol; 2020; 11():960. PubMed ID: 32582150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stress Signal ULBP4, an NKG2D Ligand, Is Upregulated in Multiple Sclerosis and Shapes CD8
    Carmena Moratalla A; Carpentier Solorio Y; Lemaitre F; Farzam-Kia N; Levert A; Zandee SEJ; Lahav B; Guimond JV; Haddad E; Girard M; Duquette P; Larochelle C; Prat A; Arbour N
    Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34873031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. STAT3 inhibition by STA21 increases cell surface expression of MICB and the release of soluble MICB by gastric adenocarcinoma cells.
    Garrido-Tapia M; Hernández CJ; Ascui G; Kramm K; Morales M; Ga Rate V; Zúñiga R; Bustamante M; Aguillón JC; Catala N D; Ribeiro CH; Molina MAC
    Immunobiology; 2017 Nov; 222(11):1043-1051. PubMed ID: 28578917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Fc-optimized NKG2D-immunoglobulin G fusion protein for induction of natural killer cell reactivity against leukemia.
    Steinbacher J; Baltz-Ghahremanpour K; Schmiedel BJ; Steinle A; Jung G; Kübler A; André MC; Grosse-Hovest L; Salih HR
    Int J Cancer; 2015 Mar; 136(5):1073-84. PubMed ID: 25046567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chimeric NKG2D CAR-expressing T cell-mediated attack of human ovarian cancer is enhanced by histone deacetylase inhibition.
    Song DG; Ye Q; Santoro S; Fang C; Best A; Powell DJ
    Hum Gene Ther; 2013 Mar; 24(3):295-305. PubMed ID: 23297870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rae1 drives NKG2D binding-dependent tumor development in mice by activating mTOR and STAT3 pathways in tumor cells.
    Zhao P; Yang L; Li X; Lu W; Lu F; Wang S; Wang Y; Hua L; Cui C; Dong B; Yu Y; Wang L
    Cancer Sci; 2020 Jul; 111(7):2234-2247. PubMed ID: 32333709
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Qin XR; Wu J; Yao XY; Huang J; Wang XY
    Saudi J Gastroenterol; 2019; 25(3):181-187. PubMed ID: 30618438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activated and expanded natural killer cells target osteosarcoma tumor initiating cells in an NKG2D-NKG2DL dependent manner.
    Fernández L; Valentín J; Zalacain M; Leung W; Patiño-García A; Pérez-Martínez A
    Cancer Lett; 2015 Nov; 368(1):54-63. PubMed ID: 26276724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural Killer Group 2, Member D/NKG2D Ligands in Hematopoietic Cell Transplantation.
    Carapito R; Aouadi I; Ilias W; Bahram S
    Front Immunol; 2017; 8():368. PubMed ID: 28396673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IDO1 can impair NK cells function against non-small cell lung cancer by downregulation of NKG2D Ligand via ADAM10.
    Fang X; Guo L; Xing Z; Shi L; Liang H; Li A; Kuang C; Tao B; Yang Q
    Pharmacol Res; 2022 Mar; 177():106132. PubMed ID: 35183714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-like receptor 4 engagement contributes to expression of NKG2D ligands by renal tubular epithelial cells.
    Chen GE; Wu H; Ma J; Chadban SJ; Sharland A
    Nephrol Dial Transplant; 2011 Dec; 26(12):3873-81. PubMed ID: 21555390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori.
    Schmausser B; Andrulis M; Endrich S; Müller-Hermelink HK; Eck M
    Int J Med Microbiol; 2005 Jun; 295(3):179-85. PubMed ID: 16044857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori lipopolysaccharides upregulate toll-like receptor 4 expression and proliferation of gastric epithelial cells via the MEK1/2-ERK1/2 mitogen-activated protein kinase pathway.
    Yokota S; Okabayashi T; Rehli M; Fujii N; Amano K
    Infect Immun; 2010 Jan; 78(1):468-76. PubMed ID: 19858308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.